Treatment of postoperative nausea and vomiting with dolasetron versus ondansetron: is there a conflict of interest?
- PMID: 16301287
- DOI: 10.1213/01.ANE.0000180267.47426.18
Treatment of postoperative nausea and vomiting with dolasetron versus ondansetron: is there a conflict of interest?
Comment in
-
Ethics, marketing, and the medical literature.Anesth Analg. 2006 Aug;103(2):488; discussion 488; author reply 488-9. doi: 10.1213/01.ANE.0000227075.06595.3A. Anesth Analg. 2006. PMID: 16861440 No abstract available.
Comment on
-
Dolasetron versus ondansetron for the treatment of postoperative nausea and vomiting.Anesth Analg. 2005 Feb;100(2):373-377. doi: 10.1213/01.ANE.0000144421.96275.D1. Anesth Analg. 2005. PMID: 15673860 Clinical Trial.
References
-
- Meyer TA, Roberson CR, Rajab CR, et al. Dolasetron versus ondansetron for the treatment of postoperative nausea and vomiting. Anesth Analg 2005;100:373–7.
-
- Zarate E, Watcha MF, White PF, et al. A comparison of the costs and efficacy of ondansetron versus dolasetron for antiemetic prophylaxis. Anesth Analg 2000;90:1352–8.
-
- Sukhani R, Pappas AL, Luire J, et al. Ondansetron and dolasetron provide equivalent postoperative vomiting control after ambulatory tonsillectomy in dexamethasone-pretreated children. Anesth Analg 2002;95:1230–5.
-
- Olutoye O, Jantzen EC, Alexis R, et al. A comparison of the cost and efficacy of ondansetron and dolasetron in the prophylaxis of postoperative vomiting in pediatric patients undergoing ambulatory surgery. Anesth Analg 2003;97:390–6
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
